Trends in comorbid chronic kidney disease and atrial fibrillation‐related cardiovascular mortality in the United States-Reference-Cited by-同舟云学术

Trends in comorbid chronic kidney disease and atrial fibrillation‐related cardiovascular mortality in the United States

Published:2024-01-16 Issue: Volume: Page:
ISSN:1880-4276
Container-title:Journal of Arrhythmia
language:en
Short-container-title:Journal of Arrhythmia

Author:

Ibrahim Ramzi¹^ORCID,Singh Vikram J.¹,Tan Min Choon²³,Singh Simar J.¹,Shahid Mahek¹,Elchouemi Mohanad⁴,Gianni Carola⁴,Lee Justin Z.⁵,Al‐Ahmad Amin⁴

Affiliation:

1. Department of Internal Medicine University of Arizona—Banner University Medical Center Tucson Arizona USA

2. Department of Cardiovascular Medicine Mayo Clinic Phoenix Arizona USA

3. Department of Internal Medicine New York Medical College at Saint Michael's Medical Center Newark New Jersey USA

4. Texas Cardiac Arrhythmia Institute, St. David's Medical Center Austin Texas USA

5. Department of Cardiovascular Medicine Cleveland Clinic Cleveland Ohio USA

Abstract

AbstractBackgroundThe impact of chronic kidney disease (CKD) on atrial fibrillation outcomes (AF) is not well understood.MethodsWe conducted analyses of comorbid AF and CKD related death in the United States from 1999 to 2020 using descriptive epidemiology.ResultsAge‐adjusted mortality rates (AAMR) per 100,000 increased from 0.39 in 1999 to 1.65 in 2020. Non‐Hispanic populations (1.01) and nonmetropolitan areas (1.08) had higher AAMRs compared to Hispanic (0.62) and metropolitan (0.97) areas. Midwestern (1.11) and Western (1.13) US regions recorded the highest AAMRs.ConclusionsThese findings highlight the need for interventions to address AF death disparities in patients with CKD.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/joa3.12990

Reference15 articles.

1. Role of Hemostatic Factors on the Risk of Venous Thrombosis in People With Impaired Kidney Function

2. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis

3. Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

4. Center for Disease Control and Prevention National Center for Health Statistics.CDC wonder: multiple cause of death 1999–2020. Center for Disease Control and Prevention; November 2022.